Infirmary. The study is designed to determine the precise prognostic significance of a positive (and negative) bone scan in the assessment of primary breast cancer patients. Our preliminary results suggest that the lesions demonstrated do represent clinically significant metastatic disease. Because of the convenience and safety of 9aTcm-EHDP, serial scans are possible. We scan all our post-mastectomy patients at regular sixmonthly intervals, or more frequently if there is any clinical suspicion of local recurrence or metastases. There appears to be emerging a group of patients in whom serial scans reveal progression of occult metastases during what would previously be considered a 'tumour-free' interval, when clinical symptoms and signs are absent and skeletal radiographs are normal. The therapeutic significance of such early diagnosis must now be considered.
In the treatment of established bone metastases it has been suggested that the scan may provide evidence of response to systemic therapy (Galasko & Doyle 1972) . For these purposes we have developed a simple non-invasive method for quantitating the activity of skeletal lesions, independent of the variable exposure of the gamma camera polaroid scan (Citrin, Bessent, Tuohy, Greig & Blumgart 1974) .
We are now using this method to study the response of occult metastases to systemic treatment. We believe the method may be particularly valuable in the management of asymptomatic radiologically normal scan positive patients in whom there may be no other available method for assessing therapeutic effects.
The ability to demonstrate and quantitate the activity of skeletal metastases in a patient with an 'early' breast tumour or a patient who remains well after an apparently -successful primary operation, introduces entirely new therapeutic opportunities. It is possible that serial quantitative bone scans may provide a rapid means of determining whether a particular therapy will be of value in inducing a remission. Further research is now urgently needed to establish whether the improved diagnostic accuracy of the bone scan will reduce the morbidity and mortality of breast cancer, by facilitating earlier and more appropriate treatment.
Dr M V Merrick (RoyalPostgraduate Medical School, London W12; Western General Hospital, Edinburgh, EH4 2XU) An Appraisal ofImaging Methods to Detect Disease ofthe Adrenal Glands, the Pancreas and the Parathyroids Of the three investigations listed in the title, only pancreas scanning is widely used at the present time. There is no known substance which accumulates exclusively in the pancreas, although there are a number which concentrate to a greater extent in this organ than they do in the liver. Various such compounds have been investigated, but only one has established itself clinically, namely selenomethionine. This is the aminoacid methionine, with the sulphur atom replaced by a selenipm atom. It is synthesized by microorganisms growing in an environment depleted in sulphur and enriched in selenium. The final product is not pure selenomethionine but is a mixture of natural aminoacids, selenomethionine and sodium-selenite.
There is considerable disagreement between various centres on the accuracy of pancreas scanning. Figures as low as 37 % (Rankin & Brown 1964) and as high as 90% (Asnies & Johansen 1970) have been quoted in different series. There can be little doubt that this does to some extent reflect-differences in selection of patients for this investigation, but may also be due to differences in the technique employed. There are four possible ways of scanning the pancreas: (1) A straightforward rectilinear scan using only selenomethionine. (2) A rectilinear scan after the administration of both seleno-methionine and a second isotope which goes only to the liver, and then in some way subtracting one picture from the other. (3) Using a gamma camera instead of a rectilinear scanner. (4) Using a gamma camera and at the same time stimulating the pancreas.
On a straightforward rectilinear scan the pancreas is often difficult to identify.' Giving a second, liver-seeking, radioisotope and subtracting electronically one from the other usually permits the pancreas to be made out fairly clearly. However, the statistics of the subtracted picture are poor and the resolution, i.e. the smallest lesion which it is possible to detect, is correspondingly largeprobably about 5 cm diameter.
If the gamma camera is used, it is possible to tilt the camera head so that it is looking cephalad 'under' the liver, and it is usually possible in this way to project the liver clear of the pancreas without the use of additional complex electronic equipment. However, this technique requires very careful supervision, and when left to a technician is often unsuccessful.
With any of these techniques the pancreas can be made out in a very high percentage of normal patients and a number of variants of the normal shape have been described (McCready & Cottrall 1971) . In our experience, filling defects are not commonly identified in the pancreas and on theoretical grounds it is doubtful whether it is possible with existing equipment to detect lesions less than 5 cm in diameter with any useful degree of reliability.
In an attempt to improve the accuracy Nundy et al. (1974) used a battery of ten tests performed simultaneously. The patient was intubated with a double lumen tube, and the gastric contents aspirated via one lumen and discarded. The duodenal contents were aspirated and analysed for total volume, bicarbonate concentration and output, tryptic concentration and output and selenium concentration and output. In addition samples were taken for cytology and a scan and hypotonic duodenogram performed. The scan was the investigation least often correct and cytology the most often correct; however, by combining all the results a higher percentage accuracy was achieved than was obtained with any single investigation. It must be pointed out that this examination was performed while the pancreas was being stimulated by a continuous infusion of secretin and pancreozymin. Under these circumstances, although the output of the pancreas is considerably increased, the image obtained is very much poorer than with the unstimulated pancreas. A good discrimination was obtained between normal and abnormal but not between chronic pancreatitis and carcinoma.
Thus the application of pancreas scanning is restricted. A normal pancreas scan indicates that primary disease of the pancreas is very unlikely, and it is therefore useful as an investigation of exclusion. However, systemic disease of almost any origin, and in particular disease of the gastro-intestinal tract, will commonly give nonvisualization even in the absence of involvement of this organ. Operable mass lesions of the pancreas are diagnosed only on rare occasions.
The same radiopharmaceutical, selenomethionine is also used for visualization of the parathyroids. This investigation has achieved very limited acceptance. It can detect occasional large adenomas usually of 2-5 g in weight, but hitherto no success has been reported with the much more common smaller tumours. However, Ell et al. (1975) of the Department of Nuclear Medicine at the Middlesex Hospital, have recently had the opportunity of investigating 36 patients with hyperparathyroidism. None had a palpable mass in the neck. Their technique was to perform a conventional analogue scan using selenomethionine, and simultaneously to give the patient iodine-125. The rationale of this is that both selenomethionine and iodine are taken up by the thyroid. Using a sophisticated technique of computer analysis they were able to localize parathyroid adenomas in 16 out of the 30 patients in whom they obtained technically adequate scans. The tumours were confirmed at operation in 14 out of these 16 and in 10 they weighed 1.5 g or less. In two cases the scan gave a false positive result, and there were three false negatives amongst the 14 patients in whom nothing was found on the scan. These results need confirmation by a prospective study, and comparison with established techniques such as the barium swallow is desirable. Dr Britton has informed me that he is anxious to obtain further experience with this technique and would be very happy to examine any patieDt referred to him. Because of the complex computer programming which is necessary in order to analyse these scans, this technique is not one which at the moment could readily be performed in any other centre.
Of at least equal interest are the results which have recently been reported for radioisotope imaging of the adrenal cortex. A number of compounds have been investigated but only one has proved of value in man -19-iodocholesterol. This compound was synthesized by Counsell Table 1 Absorbed dose from 2 mCi of "3'1-iodocholesterol (1970) as part of a systematic study of iodinated cholesterol analogues. lodination at other, more readily accessible, sites results in a compound which is rapidly deiodinated in vivo. This compound is thermally unstable and on standing at room temperature slowly decomposes. It is insoluble in water but may be made up for injection in aqueous ethanol and polysorbate-80.
No adverse effects have been noted following its intravenous administration in more than 200 patients, except in one or two cases where it was given as a rapid bolus, when there was some transitory pain in the vein into which it was injected, and a feeling of 'light headedness'. This does not occur if a slow injection is made (Beierwaltes 1974, personal communication) . The usual dose is 2 mCi of 1311 labelled to 1-2 mg of the iodocholesterol. The radiation dose involved is high by comparison with many radioisotope diagnostic procedures (Table 1) . However, to put this into perspective, fluoroscopy with equipment in current use, such as the image intensifier and television chain, involves a dose of approximately one rad per minute of screening time at the skin nearest the X-ray tube. Mammography using an unfiltered low kV tube delivers a dose to the skin of up to 15 rads per exposure. Thus although the dose from 2 mCi is undoubtedly high, it is not out of proportion to other diagnostic tests performed for well defined indications.
After intravenous administration the compound is taken up principally by the liver and the adrenals. The initial uptake by the liver is lost fairly rapidly, while the activity taken up by the adrenals is retained. Normal adrenals can sometimes be visualized four days after injection, at which time hyperactive adrenals can always be visualized. It is preferable, however, to wait at least six days between injection and starting the examination. Scans are then performed at daily intervals, if necessary for up to three weeks after the injection.
Excretion is largely urinary and is probably in the form of free iodide, suggesting that the compound is degraded before excretion. For this reason patients are given Lugol's iodine for three weeks from the start of the investigation to block the thyroid. The experience gained to date (Anderson & Beierwaltes 1974) gives a number of indications for adrenal scanning. These are: (1) Unilateral hyperfunction due to adrenal cortical adenoma or aldosterone secreting tumours. (2) Unilateral hypofunction due to infarction, infection, surgery or carcinoma. (3) Functioning remnant. (4) Steroid therapy. (5) Virilism.
Imaging of the adrenals is useful only when there is asymmetry of function, for imaging alone does not distinguish a normal from a hyperfunctioning gland. The available evidence suggests that uptake measurements are useful in this respect and it is difficult to envisage what information can be obtained by imaging that cannot equally or better be obtained by uptake measurements. It seems likely that the latter may be performed with a much smaller amount of radioisotope. In view of the high radiation dose involved, further experience is clearly required before this can be accepted as a routine investigation. However, the clinical experience already available is more than adequate justification for performing such a trial.
